Top 300 Pharmacy Drug Cards

MEASLES, MUMPS, RUBELLA VACCINE, LIVE: MMR-II

Class: Vaccine

Dosage Forms. Lyophilized Powder for Subcutaneous Injection: 0.5 mL after reconstitution with supplied diluent; also available in combination with varicella vaccine

Image

Common FDA Label Indication, Dosing, and Titration.

1. Prevention of measles, mumps, and rubella infections: Adults, one dose (second dose indicated for adults who are at high risk); Children, one dose at age 12 mo with a second dose at age 4-6 y, prior to entering school

Off-Label Uses. None

Drug Characteristics: Measles, Mumps, Rubella Vaccine, Live

Image

Medication Safety Issues: Measles, Mumps, Rubella Vaccine, Live

Image

Drug Interactions: Measles, Mumps, Rubella Vaccine, Live

Image

Adverse Reactions: Measles, Mumps, Rubella Vaccine, Live

Image

Efficacy Monitoring Parameters. Prevention of measles, mumps, and rubella infections; although antibody concentrations might be measured, routine measurement for vaccine response is not recommended.

Toxicity Monitoring Parameters. Syncope within 15 min of vaccine administration.

Key Patient Counseling Points. Some children may experience mild fever and rash 7-10 d after vaccine administration. Avoid pregnancy for 28 d following vaccine administration.

Clinical Pearls. Individuals born before 1957 can be considered immune unless a female of childbearing potential. Administer to females found to be seronegative to rubella following completion of pregnancy. If not administered simultaneously, MMR must be separated by at least 4 wk from other live vaccines. Individuals vaccinated between 1963 and 1967 with killed measles vaccine should be revaccinated. Individuals vaccinated before 1979 with inactivated mumps vaccine should be revaccinated. Avoid confusion with MMRV, which also contains varicella vaccine.